BRABOURNE

Rpg Life Sciences Limited has informed the Exchange that Mr. Rajendra A. Shah on the date of assuming office of director / officer on June 27, 2006 has acquired nil shares of Rpg Life Sciences Limited.

Rpg Life Sciences Limited has informed the Exchange that Mr. Dilip Sen who has been appointed as director of the Company on January 18, 2006, holds Nil shares of the Company.

Rpg Life Sciences Limited has informed the Exchange that the Remuneration / Compensation of the Committee has on October 19, 2005 granted stock options to the employees under Employee Stock Option Scheme of the Company, for 1,07,150 shares at exercise price of Rs. 120 per share. The closing price on the BSE (being the exchange with highest trading) on October 18, 2005 was Rs. 119.40. The options shall vest, in accordance with the scheme of the Company, after one year from the date of grant. The employees who continue to be in employment or those who retire in normal course shall have time of 1

Rpg Life Sciences Limited has informed the Exchange that Mr. P K Mohapatra who has been appointed as an additional director of the Company on July 28, 2005, holds Nil shares of the Company.

Rpg Life Sciences Limited has informed the Exchange regarding the sale of shares by OffShore India Limited and Jubilee Investments & Industries Limited and the purchase of share by Bespoke Finvest Limited. The details are follows: (1) Bespoke Finvest Limited has acquired 18,50,000 Equity Shares aggregating to 14.88% of the paid-up capital of RPG Life Sciences Limited on March 30, 2005. The mode of acquisition is Inter se transfer amongst promoters and the shareholding of Bespoke Finvest Limited after the said acquisition is 18,50,000 Equity Shares aggregating to 14.88% of the share capital of

Bespoke Finvest Limited has informed the Exchange that they have acquired 18,50,000 Equity Shares aggregating to 14.88% of the paid-up capital of RPG Life Sciences Limited. The date of acquisition is March 30, 2005 and the mode of acquisition is Inter se transfer amongst promoters. The shareholding after the said acquisition of (i) Bespoke Finvest Limited by itself, is 18,50,000 Equity Shares aggregating to 14.88%, and (ii) Bespoke Finvest Limited together with Holding company is 18,50,100 Equity Shares aggregating to 14.89%, of the total paid-up capital of RPG Life Sciences Limited.

Jubilee Investments & Industries Ltd has informed the Exchange that they have sold 10,00,000 Equity Shares aggregating to 8.05% of the total paid-up capital of RPG Life Sciences Limited on March 30, 2005. The mode of sale is Inter se transfer and the shareholding of Jubilee Investments & Industries Ltd. after the said sale is 2,26,654 Equity Shares aggregating to 1.82% of the total paid-up capital of RPG Life Sciences Limited.

Off-Shore India Ltd has informed the Exchange that they have sold 6,07,500 Equity Shares aggregating to 4.89% of the total paid-up capital of RPG Life Sciences Limited on March 30, 2005. The mode of sale is through Inter se transfer and the shareholding of Off-Shore India Ltd. after the said sale is 2,76,866 Equity Shares aggregating to 2.23% of the total paid-up capital of RPG Life Sciences Limited.